Neural transplantation for Parkinson's disease
- PMID: 10079966
- PMCID: PMC11545433
- DOI: 10.1023/a:1006964507916
Neural transplantation for Parkinson's disease
Abstract
1. Neural transplantation is one promising approach for the treatment of Parkinson's disease. Fetal substantia nigra cells are a good source of dopamine, but in order to avoid ethical and immunological problems, adrenal medullary chromaffin cells have been investigated as an alternative source. 2. Grafted adrenal medullary chromaffin cells can provide dopamine as well as several neurotrophic factors that affect dopaminergic neurons in the brain. 3. We review experimental studies for application of neural transplantation techniques in Parkinson's disease, including immunological studies, cryopreservation, microvasculature, donor tissue, and direct gene delivery studies performed in our laboratory. Our clinical experience and new approach involving a polymer-encapsulated cell grafting procedure are also described.
References
-
- Acheson, A., Barker, P. A., Alderson, R. F., Miller, F. D., and Murphy, R. A. (1991). Detection of brain-derived neurotrophic factor-like activity in fibroblasts and Schwann cells: Inhibition by antibodies to NGF. Neuron7:265–275. - PubMed
-
- Bakay, R. A. E. (1993). Neurotransplantation: A clinical update. Acta Neurochir. 58(Suppl):8–16. - PubMed
-
- Bjorklund, A., and Stenevi, U. (1979). Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res.177:555–560. - PubMed
-
- Bohn, M. C., Cupit, L., Marciano, F., and Gash, D. M. (1987). Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science237:913–916. - PubMed
-
- Broadwell, R. D., Charlton, H. M., Ebert, P., Hickey, W. F., Villegas, J. C., and Wolf, A. L. (1990). Angiogenesis and the blood-brain barrier in solid and dissociated cell grafts within the CNS. Prog. Brain Res.82:95–101. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical